{
  "id": "PK_PGP_INHIB_DIGOXIN",
  "name": "P-gp inhibition can increase exposure of P-gp substrates",
  "domain": "PK",
  "severity": "major",
  "rule_class": "adjust_monitor",
  "tags": ["exposure_increase"],
  "scenario": {
    "classification": "reference",
    "index_drug": "digoxin",
    "confidence": "high",
    "notes": "Reference P-gp inhibition interaction involving a narrow therapeutic index substrate."
  },
  
  "actions": [
    "Use caution when combining P-gp inhibitors with narrow-TI substrates.",
    "Monitor for toxicity symptoms related to increased exposure.",
    "Recognize that transporter effects can be context-dependent."
  ],
  "logic": {
    "transporter": {
      "id": "P-gp",
      "A_role": "substrate",
      "B_role": "inhibitor"
    },
    "A_ti": "narrow",
    "rationale": [
      "{B_name} inhibits P-gp, reducing efflux of {A_name}.",
      "Even modest exposure increases may be clinically important for narrow-TI drugs."
    ]
  },
  "explanation_template": "{B_name} inhibits P-gp and {A_name} is a P-gp substrate with a narrow therapeutic index. This can increase systemic exposure and toxicity risk.",
  "references": [
    {
      "source": "Educational note",
      "citation": "Transporter inhibition + narrow therapeutic index increases risk even with modest changes."
    }
  ]
}
